Esperion Therapeutics, Inc. (NASDAQ:ESPR) Reported Basic Consolidated EPS Of $-2.2609

0

For the period ended 2015-12-31, Esperion Therapeutics, Inc. (NASDAQ:ESPR) reported $-2.2609 as the annual basic consolidated EPS. On quarterly basis, $-2.2609 was captured as the basic consolidated EPS reading for the quarter ended 2015-12-31.

EPS from continuing operations

For the annual period ended 2015-12-31 and in line with the basic EPS from continuing operations Esperion Therapeutics, Inc. (NASDAQ:ESPR) reported $-2.2609. For the three-month period ended 2015-12-31, quarterly basis EPS from continuing operations stood at $-2.2609.

EPS contribution from parent

Basic EPS received by Esperion Therapeutics, Inc. (NASDAQ:ESPR) from its parent company was $-2.2609 for the annual period ended 2015-12-31. For the period ended 2015-12-31, the quarterly basis the basic EPS contribution from the parent company was $-2.2609.

Basic net EPS

Esperion Therapeutics, Inc. (NASDAQ:ESPR) reported basic net EPS of $-2.26 for the annual period ended 2015-12-31. The company’s basic net EPS on a quarterly basis stood at $-2.26 for the three-month period ended 2015-12-31.

Consolidated diluted EPS

The period ended 2015-12-31 had an annual consolidated diluted EPS reading of $-2.2609. Consolidated diluted EPS for the quarter ended 2015-12-31 was $-2.2609.

b>Basic diluted EPS

For the period ended 2015-12-31 diluted EPS reading from continuing operation on annual basis was $-2.2609. However, $-2.2609 was registered as the Diluted EPS from continuing operations for the quarter ended 2015-12-31.

Net diluted EPS

For the annual period ended 2015-12-31, $-2.26 was the Net diluted EPS reading. But the quarterly period that ended 2015-12-31, net diluted EPS was $-2.26.

Diluted EPS from parent

Esperion Therapeutics, Inc. (NASDAQ:ESPR) received diluted EPS of $-2.2609 from the parent company which was for the annual period ended 2015-12-31. However, on quarterly basis, $-2.2609 was the diluted EPS contribution from the parent for the quarter ended 2015-12-31. The net basic EPS reading of $-2.26 was posted by Esperion Therapeutics, Inc. (NASDAQ:ESPR) which was representing the annual period ended 2015-12-31. Basic net EPS of $-2.26 was for the quarter ended 2015-12-31.

For the annual period ended 2015-12-31, Net diluted EPS was $-2.26 for the annual period ended 2015-12-31. There was also a report by the company of $-2.26 being the net diluted EPS reading for the quarter ended 2015-12-31.

While the shares for the quarter ended 2015-12-31 were at 22.542, the period ended 2015-12-31 is 22.542 being the annual average basic shares outstanding.

For the fiscal year ended is 2015-12-31 while 22.542 represents the quarter ended 2015-12-31.

1 Chart Pattern Every Investor Should Know

This little-known pattern preceded moves of 578% in ARWR, 562% in LCI, 513% in ICPT, 439% in EGRX, 408% in ADDUS and more...

Click Here to See This Now.

(Visited 21 times, 1 visits today)